COVID-19: No benefit of plasma therapy in reducing mortality risk, says AIIMS Director Dr Randeep Guleria

The therapy involves taking antibodies from the blood of a person who has recovered from COVID-19 and transfusing those into an active coronavirus infected patient to help kickstart the immune system to fight back the infection.

from Zee News :Zee News - Health https://ift.tt/3ifY17f
via IFTTT